Latest Shareholder Participation News

LGI Limited has successfully raised $51.2 million through a placement and launched a $5 million Share Purchase Plan to fund key renewable energy projects and strengthen its balance sheet.

Barton Gold Holdings Limited has launched a $2.5 million Share Purchase Plan alongside a $15 million placement, offering eligible shareholders a chance to invest at $1.25 per share to support critical project development.

WAM Strategic Value Limited has confirmed a fully franked final dividend of AUD 0.03 per share for the financial year ending June 2025, alongside an updated Dividend Reinvestment Plan price.

Alice Queen Limited (ASX – AQX) is set to raise $1 million through a two-tranche share placement accompanied by free-attaching options, alongside a bonus loyalty option offer to existing shareholders.

Barton Gold Holdings has secured $15 million through an institutional placement led by Franklin Templeton, with a $2.5 million Share Purchase Plan opening to shareholders. The capital raise supports the company’s goal to commission Stage 1 production by the end of 2026 in South Australia’s Gawler Craton.

Catapult Sports has launched a Share Purchase Plan (SPP) offering eligible shareholders in Australia and New Zealand the chance to buy shares at a discount, following a recent A$130 million institutional placement and its acquisition of IMPECT GmbH.

Clara Resources Australia Ltd has raised $1.6 million through a placement and a fully underwritten rights issue, aiming to accelerate development of its Ashford Coking Coal Project in New South Wales.

Alligator Energy Limited has released its comprehensive company constitution, detailing governance, shareholder rights, and director responsibilities under Australian law and ASX rules. This foundational document sets the framework for the company’s operations and compliance.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

Southern Palladium has raised A$20 million through a strategic share placement to accelerate its Bengwenyama PGM project, positioning the company for key milestones including a Final Investment Decision in 2026.

Radiopharm Theranostics has completed a A$35 million institutional placement and launched a A$5 million Share Purchase Plan, both at $0.03 per share, to fund drug manufacturing and clinical trials through 2027.

Reece Limited has completed a $365 million off-market share buy-back, repurchasing 4.3% of its shares at $13 each with no scale-back applied. This move returns excess capital to shareholders while preserving financial flexibility for future growth.